These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 28373439)
1. Characterization of Leiomyomatoid Angiomatous Neuroendocrine Tumour (LANT)-like Tumour in the Myometrium with Histopathological Examination. Hayashi T; Ichimura T; Kasai M; Sano K; Zharhary D; Shiozawa T; Yaegashi N; Konishi I Anticancer Res; 2017 Apr; 37(4):1765-1772. PubMed ID: 28373439 [TBL] [Abstract][Full Text] [Related]
2. A leiomyomatoid angiomatous neuroendocrine tumor of the myometrium: case study with ultrastructural analysis. Sakashita N; Yamada M; Nakagawa T; Yamasaki H; Takeya M Hum Pathol; 2008 May; 39(5):788-92. PubMed ID: 18439943 [TBL] [Abstract][Full Text] [Related]
3. Reduced expression of calponin h1 in leiomyosarcoma of the uterus. Horiuchi A; Nikaido T; Ito K; Zhai Y; Orii A; Taniguchi S; Toki T; Fujii S Lab Invest; 1998 Jul; 78(7):839-46. PubMed ID: 9690561 [TBL] [Abstract][Full Text] [Related]
4. Leiomyomatoid angiomatous neuroendocrine tumor (LANT) of the pituitary: a distinctive biphasic neoplasm with primitive secretory phenotype and smooth muscle-rich stroma. Vajtai I; Sahli R; Kappeler A; Christ ER; Seiler RW Acta Neuropathol; 2006 Mar; 111(3):278-83. PubMed ID: 16520966 [TBL] [Abstract][Full Text] [Related]
5. Potential role of LMP2 as an anti-oncogenic factor in human uterine leiomyosarcoma: morphological significance of calponin h1. Hayashi T; Horiuchi A; Sano K; Hiraoka N; Kasai M; Ichimura T; Sudo T; Nishimura R; Ishiko O; Shiozawa T; Kanai Y; Yaegashi N; Aburatani H; Konishi I FEBS Lett; 2012 Jun; 586(13):1824-31. PubMed ID: 22659265 [TBL] [Abstract][Full Text] [Related]
6. Potential diagnostic biomarkers: differential expression of LMP2/β1i and cyclin B1 in human uterine leiomyosarcoma. Hayashi T; Horiuchi A; Sano K; Hiraoka N; Ichimura T; Sudo T; Ishiko O; Yaegashi N; Aburatani H; Konishi I Tumori; 2014; 100(4):99e-106e. PubMed ID: 25296613 [TBL] [Abstract][Full Text] [Related]
7. "Leiomyomatoid angiomatous neuroendocrine tumor" (LANT) of the pituitary reflects idiosyncratic angiogenesis in adenomas of the gonadotroph cell lineage. Schürch C; Birrer M; Estella I; Kappeler A; Hewer E; Vajtai I Pathol Res Pract; 2013 Mar; 209(3):155-60. PubMed ID: 23419690 [TBL] [Abstract][Full Text] [Related]
8. CD56 is Expressed in Uterine Smooth Muscle Tumors. Karpathiou G; Chauleur C; Papoudou-Bai A; Dagher S; Peoc'h M Int J Gynecol Pathol; 2021 Jul; 40(4):315-323. PubMed ID: 32897962 [TBL] [Abstract][Full Text] [Related]
9. Expression of CD44 standard and isoforms V3 and V6 in uterine smooth muscle tumors: a possible diagnostic tool for the diagnosis of leiomyosarcoma. Poncelet C; Walker F; Madelenat P; Bringuier AF; Scoazec JY; Feldmann G; Darai E Hum Pathol; 2001 Nov; 32(11):1190-6. PubMed ID: 11727257 [TBL] [Abstract][Full Text] [Related]
10. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors. Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677 [TBL] [Abstract][Full Text] [Related]
11. Expression of mucin-1, galectin-1 and galectin-3 in human leiomyosarcoma in comparison to leiomyoma and myometrium. Weissenbacher T; Kuhn C; Mayr D; Pavlik R; Friese K; Scholz C; Jeschke U; Ditsch N; Dian D Anticancer Res; 2011 Feb; 31(2):451-7. PubMed ID: 21378323 [TBL] [Abstract][Full Text] [Related]
12. POTENTIAL DIAGNOSTIC BIOMARKERS FOR HUMAN MESENCHYMAL TUMORS, ESPECIALLY LMP2/Β1I AND CYCLIN E1/MIB1 DIFFERENTIAL EXPRESSION: PRUM-IBIO STUDY. Tanabe Y; Hayashi T; Okada M; Aburatani H; Tonegawa S; Abiko K; Konishi I Georgian Med News; 2024 May; (350):42-48. PubMed ID: 39089269 [TBL] [Abstract][Full Text] [Related]
13. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling. Quade BJ; Wang TY; Sornberger K; Dal Cin P; Mutter GL; Morton CC Genes Chromosomes Cancer; 2004 Jun; 40(2):97-108. PubMed ID: 15101043 [TBL] [Abstract][Full Text] [Related]
14. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential. O'Neill CJ; McBride HA; Connolly LE; McCluggage WG Histopathology; 2007 Jun; 50(7):851-8. PubMed ID: 17543074 [TBL] [Abstract][Full Text] [Related]
15. Cathepsin B in human myometrium and in uterine leiomyomas at various stages of tumour growth. Gogiel T; Wolańska M; Galewska Z; Kinalski M; Sobolewski K; Romanowicz L Eur J Obstet Gynecol Reprod Biol; 2015 Feb; 185():140-4. PubMed ID: 25577554 [TBL] [Abstract][Full Text] [Related]
17. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors. Schwetye KE; Pfeifer JD; Duncavage EJ Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187 [TBL] [Abstract][Full Text] [Related]
18. Liposarcoma arising in uterine lipoleiomyoma: a report of 3 cases and review of the literature. McDonald AG; Dal Cin P; Ganguly A; Campbell S; Imai Y; Rosenberg AE; Oliva E Am J Surg Pathol; 2011 Feb; 35(2):221-7. PubMed ID: 21263242 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of von Willebrand factor, CD34, CD31, and vascular endothelial growth factor expression in women with uterine leiomyosarcomas. Poncelet C; Fauvet R; Feldmann G; Walker F; Madelenat P; Darai E J Surg Oncol; 2004 May; 86(2):84-90. PubMed ID: 15112250 [TBL] [Abstract][Full Text] [Related]
20. Comparative expression of thioredoxin-1 in uterine leiomyomas and myometrium. Hou P; Zhao L; Li Y; Luo F; Wang S; Song J; Bai J Mol Hum Reprod; 2014 Feb; 20(2):148-54. PubMed ID: 24130091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]